Scientists test new Drug's reach into Hard-to-Treat brain tumors
NCT ID NCT02282917
Summary
This early study tested whether an experimental drug called AR-42 could reach two types of brain and nerve tumors and affect a specific protein linked to cancer growth. A small group of adults scheduled for tumor removal surgery took the drug for three weeks before their operation. Researchers then analyzed the removed tumors to see if the drug got inside them and changed their biology, which helps decide if larger treatment trials are worthwhile.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MENINGIOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Johns Hopkins University
Baltimore, Maryland, 21287, United States
-
Massachusetts Eye and Ear
Boston, Massachusetts, 02214, United States
-
Mayo Clinic
Rochester, Minnesota, 55905, United States
-
Stanford University
Stanford, California, 94305, United States
Conditions
Explore the condition pages connected to this study.